GeoVax Labs, Inc. - Common Stock – Cashflow (NASDAQ:GOVX)

Financials

Mittelzufluss aus laufender Geschäftstätigkeit -2.75 M-11.2 M-19.03 M-25.17 M-24.68 M-21.47 M -19.05 M Mittelzufluss aus Investitionstätigkeit -156.79 K-47.72 K-134.26 K-48.95 K-20.65 K-27.61 K -10.72 K Zahlungsströme aus der Finanzierungstätigkeit 12.51 M12.78 M35.35 M4.06 M23.75 M19.08 M 12.89 M Freier Cashflow -2.75 M-11.2 M-19.03 M-25.17 M-24.68 M-21.47 M -19.05 M

GeoVax Labs, Inc. - Common Stock

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated.

Nachrichten

GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marburg, Hantavirus, and Mpox Transcript

GOVX

Financials